HSBC's April 2026 note flags room for 7,000 Lenskart stores in India, resurfacing its Hold call

Resurfacing an April 2026 report, HSBC initiated Lenskart with a Rs 513 target and Hold rating, saying growth is largely priced in. The broker estimated the eyewear retailer could expand its India network from about 2,500 stores to roughly 7,000, supported by sub-one-year store payback and a growing organised market.

— FiledTue, 21 Jul, 2026, 05:35 IST·First seen Tue, 21 Jul, 2026, 05:35 IST·Source Financial Express · BrandWagon

What happened

HSBC initiated Lenskart with a Hold and Rs 513 target, saying valuation reflects growth. It sees scope for roughly 7,000 India stores from 2,500, supported by

Key facts

  • HSBC target price: Rs 513
  • Hold rating implies about 2% upside
  • Lenskart holds around 20% of India’s organised eyewear segment
  • India eyewear market expected to grow around 13% annually
  • Potential India store network: around 7,000
  • Current store count: about 2,500
  • Store payback period: less than one year

Why this matters

A tripling of Lenskart’s footprint would intensify the race for premium retail locations and accelerate consolidation opportunities among independent optical chains and regional players.

What to watch

  • Quarterly net store additions versus the pace required to approach 7,000 locations.
  • Same-store sales growth, sales per store and disclosure of new-store payback periods.
  • Franchise mix, store closure rate and evidence of cannibalization in dense urban clusters.
  • Gross-margin trends, rent and employee-cost intensity, and EBITDA performance as expansion broadens geographically.
  • Competitive responses from Titan Eye+, Specsmakers, GKB and regional optical chains.
  • Growth in organized eyewear penetration, prescription-eye-test volumes and online-to-offline conversion.
  • Increase franchise and cluster-based openings outside major metros while retaining company-operated flagship stores in high-value markets.
  • Use new stores as omnichannel service hubs for eye tests, order pickup, adjustments, returns and repeat prescription sales.
  • Deepen local marketing and affordable/private-label assortment to convert unorganized-optical customers.
  • Fund expansion through improving operating cash flow, while balancing IPO-era valuation expectations against margin protection.